Epicypher, Inc.
Biotechnology company · Durham, North Carolina, United States
Epicypher, Inc. is a biotechnology company headquartered in Durham, North Carolina, United States. Its earliest recorded incorporation is in 2012. It has received 64 US government small-business research awards (SBIR/STTR) from health agencies, $79 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $3.3 million sold in a notice filed in 2024.
Epicypher at a glance
What does Epicypher do?
US government research funding
64 SBIR/STTR small-business research awards from US health agencies, $79.2 million in total (2014 to 2025). NIH funding came from the National Institute of General Medical Sciences, National Human Genome Research Institute, National Institute of Allergy and Infectious Diseases.
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $3.3 million sold (2024).
Frequently asked questions about Epicypher
Where is Epicypher headquartered?
Epicypher, Inc. is headquartered in Durham, North Carolina, United States.
What does Epicypher do?
Epicypher, Inc. is a biotechnology company.
When was Epicypher founded?
The earliest incorporation on record for Epicypher, Inc. is in 2012, according to public company registers.
Similar companies
- Humacyte, Inc.Durham, North Carolina, United States
- Precision Biosciences IncDurham, North Carolina, United States
- Xilis, Inc.Durham, North Carolina, United States
- inSoma Bio, Inc.Durham, North Carolina, United States
- Atsena Therapeutics, Inc.Durham, North Carolina, United States
- Scion Neurostim, Inc.Durham, North Carolina, United States
- Sapere Bio, Inc.Durham, North Carolina, United States
- BioAesthetics CorpDurham, North Carolina, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences